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ABSTRACT
Aims: Light-to-moderate drinking has been associated
with reduced risk of heart failure (HF). We have
examined the association between alcohol
consumption and incident HF in older British men.
Methods and results: Prospective study of 3530
men aged 60–79 years with no diagnosed HF or
myocardial infarction (MI) at baseline and followed up
for a mean period of 11 years, in whom there were 198
incident HF cases. Men were divided into 6 categories
of alcohol consumption: none, <1, 1–6, 7–13, 14–34
and ≥35 drinks/week. There was no evidence that
light-to-moderate drinking is beneficial for risk of HF.
Heavy drinking (≥35 drinks/week) was associated with
significantly increased risk of HF. Using the large group
of men drinking 1–6 drinks/week as the reference
group, the relative HRs (95% confidence interval) for
HF adjusted for age, lifestyle characteristics, blood
pressure, atrial fibrillation and renal dysfunction were
0.97 (0.59 to 1.63), 1.39 (0.86 to 2.25), 1.00, 0.94
(0.64 to 1.43), 1.16 (0.78 to 1.71) and 1.91 (1.02 to
3.56) for the 6 alcohol groups, respectively. The
increased risk associated with heavy drinking was
attenuated after adjustment for N-terminal pro-brain
natriuretic peptide (NT-proBNP) (HR=1.43 (0.76 to
1.69)). Stratified analysis showed heavy drinking was
associated with increased HF risk only in those with
ECG evidence of myocardial ischaemia.
Conclusions: There was no evidence that light-to-
moderate drinking is beneficial for the prevention of HF
in older men without a history of an MI. Heavier
drinking (≥5 drinks/day), however, was associated with
increased risk of HF in vulnerable men with underlying
myocardial ischaemia.
INTRODUCTION
Heart failure (HF) is a major and increasingly
important public health problem in older
people and is associated with considerable
hospitalisation and mortality.1 Although it is
well documented that high levels of alcohol
intake (generally >90 g/day alcohol or more
than 9 UK standard drinks) and alcohol
abuse can result in alcoholic cardiomyopathy
leading to HF,2–4 a meta-analysis and several
prospective studies, predominantly from the
USA and mostly conducted in middle-aged
populations, have suggested that light-to-
moderate drinking may be beneﬁcial for risk
of HF.5–12 However, this pattern was not
observed in a large Finnish study13 and in the
SAVE trial,14 and some studies suggest that no
beneﬁcial effect on incident HF is seen with
light or moderate drinking (1–2 drinks/day)
KEY MESSAGES
What is already known about this subject?
▸ Light-to-moderate drinking is associated with
reduced risk of heart failure (HF) in middle-aged
populations. High levels of alcohol, usually more
than 90 g/day (>9 standard UK drinks), and
alcohol abuse can result in alcoholic cardiomyop-
athy leading to HF. Less is known about the influ-
ence of alcohol on HF in older adults in whom
incident HF is high, and the level of alcohol
intake which increases HF risk is uncertain.
What does this study add?
▸ We have examined the influence of light-to-
moderate drinking and heavy drinking on risk of
incident HF in an older population in whom HF
is often not preceded by a myocardial infarction
(MI), and assessed the effects of alcohol
on N-terminal pro-brain natriuretic peptide
(NT-proBNP) (marker of cardiac dysfunction).
The study does not provide evidence that
light-to-moderate drinking is protective in older
adults, and that drinking 5 or more drinks is
associated with significantly increased risk of HF
compared with lighter drinkers in those with
underlying ischaemia.
How might this impact on clinical practice?
▸ Heavier drinking (5 or more drinks/day), particu-
larly in those with underlying ischaemia, should
be avoided. There is no evidence for a beneficial
effect of light-to-moderate drinking to prevent
HF in men aged over 60 years who have no
history of an MI, although there was also no evi-
dence of harm from light-to-moderate drinking
in those without MI.
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when HF is not preceded by a myocardial infarction
(MI).11 This suggests that the lower risk of HF associated
with light-to-moderate drinking may be mediated
through beneﬁcial effects of alcohol on coronary heart
disease (CHD).11 However, few studies have examined
the association between alcohol drinking and risk of HF
in older adults, in whom the occurrence of HF with pre-
served ejection fraction is more common than HF with
reduced ejection fraction15 and in whom HF is less likely
to be associated with CHD.16 Moreover, in most
population-based cohort studies which have examined
the association between alcohol consumption and HF
risk, heavier drinking (>3 drinks/day) is under-
represented and the level of alcohol intake which is asso-
ciated with increased HF risk is less certain although pro-
spective population-based studies have suggested that the
risk of developing atrial ﬁbrillation, a major risk factor
for HF, increases signiﬁcantly with 5 or more drinks/
day17 and at an even lower threshold (>3 drinks/day) in
those with cardiovascular (CV) disease (CVD).18 We
have, therefore, examined the association between
alcohol consumption and incident HF in a prospective
study of older British men aged 60–79 years with particu-
lar focus on whether heavy drinking is associated with
increased HF risk compared with lighter drinking.
PARTICIPANTS AND METHODS
The British Regional Heart Study is a prospective study
involving 7735 men aged 40–59 years drawn from one
general practice in each of 24 British towns, who were
screened between 1978 and 1980.19 The population
studied was socioeconomically representative of British
men and comprises predominantly white Europeans
(>99%). In 1998–2000, all surviving men, now aged
60–79 years, were invited for a 20th year follow-up exam-
ination. Ethical approval was obtained from all relevant
local research ethics committees. All men completed a
mailed questionnaire providing information on their
lifestyle and medical history, had a physical examination
and provided a fasting blood sample. The samples were
frozen and stored at −20°C on the day of collection and
transferred in batches for storage at −70°C until analysis,
which was carried out after no more than one freeze–
thaw cycle. The 12-lead ECGs were recorded using a
Siemens Sicard 460 instrument and were analysed using
Minnesota Coding deﬁnitions at the University of
Glasgow ECG core laboratory.20 The men were asked
whether a doctor had ever told them that they had
angina, MI (heart attack, coronary thrombosis), HF or
stroke; details of their medications were recorded at the
examination. In total, 4252 men (77% of survivors) pre-
sented for examination. Blood measurements were avail-
able for 4045 men. We excluded 117 men with prevalent
HF and a further 395 men with a history of doctor-
diagnosed MI, and 3 men with no information on
alcohol intake. We excluded men with prevalent MI
because these men are at particularly high risk of HF
and are particularly likely to receive advice to change
their lifestyle, including alcohol intake. The analyses are
thus based on 3530 men.
CV risk factors at 1998–2000
Anthropometric measurements, including body weight
and height, were carried out with participants standing
in light clothing without shoes. Details of measurement
and classiﬁcation methods for smoking status, physical
activity, social class, blood pressure, blood lipids and
forced expiratory volume in 1 s (FEV1) in this cohort
have been described.21–23 Prevalent diabetes included
men with a diagnosis of diabetes and men with
fasting blood glucose ≥7 mmol/L. Predicted glomerular
ﬁltration rate (eGFR) was estimated from serum
creatinine;24 GFR=186*((creatinine)**−1.154)*((age)**
−0.203). N-terminal pro-brain natriuretic peptide
(NT-proBNP) was determined using the Elecsys 2010
electrochemiluminescence method (Roche Diagnostics,
Burgess Hill, UK).23 NT-proBNP measurements were
performed at baseline, and not in close relation to inci-
dent events. Electrocardiographic left ventricular hyper-
trophy (LVH) was deﬁned according to relevant
Minnesota Codes (codes 3.1 or 3.3). Atrial ﬁbrillation
was deﬁned according to Minnesota Codes 8.3.1 and
8.3.3. Evidence of myocardial ischaemia on ECG was
based on Minnesota Codings 1.1–1.3 (deﬁnite, probable
or possible MI) or 4.1–4.4 and 5.1–5.3 (deﬁnite, prob-
able or possible myocardial ischaemia). In total, 102
men had silent MI on ECG with no history of a doctor
diagnosis of MI; these men were included in the study.
Alcohol intake
The men were asked to describe their current frequency
of drinking (daily, most days, weekend only, occasional,
special occasions only or none) and were asked to estimate
the number of alcoholic drinks during an average week.
The men were classiﬁed into six groups according to their
reported weekly intake: none (n=344), <1 (n=338), 1–6
(n=1259), 7–13 (n=712), 14–34 (n=740) and ≥35 drinks/
week (n=137). One UK drink=10 g alcohol.
Light-to-moderate drinking refers to those drinking up to
34 drinks/week. Heavy drinking is deﬁned as drinking
≥35 drinks/week (5 or more drinks daily). To achieve suf-
ﬁcient numbers and because previous report suggest that
risk of atrial ﬁbrillation, a major risk factor for HF, is only
elevated at levels of 5 drinks or more a day, we have used
≥35 drinks as the threshold for heavy drinking. We have
used the large group of 1–6 drinks/week as the reference
group for comparison purposes. The alcohol question-
naire used in this study has been validated using 25 bio-
chemical and haematological measurements on a single
blood sample which indicated that the reported levels of
alcohol consumption were valid on a group basis.25
Follow-up
All men have been followed up from initial examination
(1978–1980) for CV morbidity and development of
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diabetes and follow-up has been achieved for 99% of the
cohort.26 In the present analyses, all-cause mortality and
morbidity events are based on follow-up from the rescre-
ening examination in 1998–2000 to July 2010, a mean
follow-up period of 11 years (range 10–12 years).
Information on death was collected through the estab-
lished ‘tagging’ procedures provided by the National
Health Service registers. Fatal CHD events were deﬁned
as death with CHD (International Classiﬁcation of
Diseases (ICD), Ninth Revision, codes 410–414) as the
underlying code. A non-fatal MI was diagnosed accord-
ing to WHO criteria.27 Evidence of non-fatal MI and HF
was obtained by ad hoc reports from general practi-
tioners supplemented by biennial reviews of the
patients’ practice records (including hospital and clinic
correspondence) through to the end of the study
period. Possible or probable cases were not included in
incident CHD cases. Incident non-fatal HF was based on
a conﬁrmed doctor diagnosis of HF from primary care
records and where possible, veriﬁed using details of
available clinical information from primary and second-
ary care records (including symptoms, signs, investiga-
tions, treatment response) to ensure that the diagnosis
was consistent with current recommendations on HF
diagnosis.28 These data were available for 160 of the 194
non-fatal cases (82%). The incidence and determinants
of HF cases identiﬁed using this process has already
been reported and are consistent with results from other
studies.22 23 Incident HF included incident non-fatal HF
(194 cases) as well as death from HF (4 cases) as the
underlying cause (ICD, Ninth revision, code 428).
Statistical methods
The χ2 tests and the analysis of variance were used to
assess the difference in baseline characteristics between
the six alcohol groups. Cox’s proportional hazards
model was used to assess the multivariate-adjusted HR
(relative risk) by alcohol categories. The large group of
men drinking 1–6 drinks/week was used as the reference
group. The proportional hazards assumption was exam-
ined using time-varying covariates, calculating interac-
tions of predictor variables and a function of survival
time and including these in the models. Examination of
time-varying covariates indicated no violation of the pro-
portionality assumption in the sample. In multivariate
analyses, smoking (never-smokers, long-term ex-smokers
(>15 years), recent ex-smokers (<15 years) and current
smokers), social class (manual vs non-manual), physical
activity (4 groups), diabetes (yes/no), use of antihyper-
tensive treatment (yes/no), prior stroke (yes/no),
diagnosed angina (yes/no), LVH (yes/no), renal dys-
function (yes/no), and atrial ﬁbrillation (yes/no) were
ﬁtted as categorical variables. Systolic blood pressure,
body mass index, FEV1 and NT-proBNP were ﬁtted con-
tinuously. To evaluate whether alcohol predicted HF
independent of incident MI (ie, those who developed
MI during follow-up), we adjusted for incident non-fatal
MI, ﬁtting this as a time-dependent covariate.
RESULTS
During the mean follow-up period of 11 years, there were
198 incident HF cases (rate 5.9/1000 person-years) and
336 major CHD events in the 3530 men with no doctor
diagnosis of HF or MI at baseline (ie, prevalent MI).
Table 1 shows the baseline characteristics by levels of
alcohol consumption. Overall non-drinkers and heavy
drinkers (≥35 drinks/week) tended to have the most
adverse CV risk factors. In particular the non-drinkers
were the oldest group and had the highest prevalence
rates of physical inactivity, manual workers, stroke, atrial
ﬁbrillation and renal dysfunction. They also had the
highest mean levels of NT-proBNP. Since NT-proBNP is
strongly associated with age (r=0.40; p<0.0001), adjust-
ment for age attenuated the increased NT-proBNP levels
in non-drinkers and increased the mean levels in heavy
drinkers, who then showed the highest NT-proBNP
levels. Men drinking <1 drink/week in general had
characteristics close to those of non-drinkers. There was
an inverse association between alcohol intake and the
percentage of men who developed CHD during
follow-up.
Figure 1 shows the Kaplan-Meier curve of the cumula-
tive incidence of HF by levels of alcohol consumption
in men without a doctor diagnosis of MI. Heavy
drinkers showed the highest cumulative incidence of HF
followed by those drinking none or <1 drink/week.
Incidence rates and relative HR for HF at different levels
of alcohol consumption, using the large group of men
consuming (1–6 drinks/week) as the reference group,
are shown in table 2. In age-adjusted analyses, non-
drinkers and infrequent drinkers showed higher risk,
albeit non-signiﬁcantly, compared with those drinking
1–6 drinks/week. Adjustment for CV risk factors (model
3) attenuated the increased HF risk in non-drinkers and
these showed similar risk to both groups of light drin-
kers (1–6 and 7–13 drinks/week groups). Heavy drinkers
showed signiﬁcantly increased HF risk, but this persisted
even after adjustment for these CV risk factors. Further
adjustments for FEV1 (model 4) and in particular
NT-proBNP (model 5) attenuated the increased relative
risk of HF associated with heavy drinking. Further adjust-
ment for incident MI strengthened the association in
heavy drinkers, but it remained non-signiﬁcant.
Exclusion of all men who had ever reported heavy drink-
ing (>6 drinks/day since entry to the study at 40–
59 years) in model 2 made little difference to the ﬁnd-
ings. We carried out further analysis separating the 21–
34 drinks/week from the 15–34 drinks/week category.
The adjusted relative risk (95% conﬁdence interval)
were 1.00 (0.60 to 1.67), 1.43 (0.88 to 2.31), 1.00, 1.02
(0.67 to 1.57), 1.48 (0.94 to 2.34), 0.57 (0.25 to 1.31)
and 1.80 (0.96 to 3.36) for the seven groups: none, <1,
1–6, 7–14, 15–20, 21–34 and ≥35 drinks/week,
respectively.
We also examined the association between alcohol and
HF stratiﬁed by age (<70 vs ≥70 years) using non-drinkers
and men drinking <1 drink/week combined as the
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Table 1 Baseline characteristics by alcohol consumption in men without prevalent diagnosed MI or HF
Current alcohol intake (drinks/week)
Non-drinker
(N=344)
<1
(N=338)
1–6
(N=1259)
7–14
(N=712)
15–34
(N=740)
≥35
(N=137) p difference
Age (years) 69.7 (5.5) 68.8 (5.3) 68.6 (5.5) 68.5 (5.5) 67.8 (5.2) 67.4 (5.2) <0.0001
BMI (kg/m2) 26.8 (4.3) 26.7 (3.7) 26.6 (3.4) 26.8 (3.4) 27.1 (3.6) 27.0 (3.8) 0.20
Obese (%) 15.4 15.0 14.5 16.7 17.0 20.4 0.41
Current smokers (%) 18.7 16.3 10.0 11.4 12.9 22.2 <0.0001
Inactive (%) 45.8 39.4 32.1 27.0 31.0 34.1 <0.0001
Manual workers (%) 68.0 64.6 52.1 50.8 43.2 56.2 <0.0001
Past >6 drinks/day drinkers (%) 3.2 2.0 3.7 11.6 23.9 66.4 <0.0001
Stroke (%) 8.1 2.7 4.2 4.4 5.6 2.9 0.008
Atrial fibrillation (%) 3.8 3.8 2.8 3.3 3.6 1.5 0.64
Angina (%) 11.6 10.0 8.3 7.3 8.7 3.7 0.05
Diabetes (%) 14.5 14.8 10.7 12.2 12.7 15.3 0.24
On BP- lowering treatment (%) 29.9 31.6 28.8 26.9 27.8 26.3 0.70
LVH (%) 9.0 6.2 8.0 7.4 6.8 9.5 0.60
ECG evidence of ischaemia (%) 27.1 20.8 21.9 22.0 21.9 25.3 0.08
FEV1 (L) 2.47 (0.6) 2.58 (0.7) 2.67 (0.7) 2.61 (0.6) 2.64 (0.6) 2.53 (0.6) <0.0001
Heart rate (bpm) 67.1 (12.5) 67.0 (13.4) 64.6 (12.2) 65.4 (12.4) 66.6 (13.2) 69.1 (13.6) <0.0001
SBP (mm Hg) 148.4 (22.7) 147.3 (23.2) 149.4 (24.7) 150.0 (24.0) 152.5 (22.9) 157.4 (22.9) <0.0001
HDL-C (mmol/L) 1.25 (0.3) 1.25 (0.3) 1.28 (0.3) 1.36 (0.3) 1.42 (0.4) 1.61 (0.4) <0.0001
GGT (IU/L)* 25.8 (18–33) 25.2 (17–34) 26.3 (18–35) 29.1 (19–37) 33.8 (25–46) 45.6 (27–31) <0.0001
eGFR (mL/min/1.73 m2) 71.1 (13.9) 71.9 (14.5) 71.7 (12.3) 72.7 (12.6) 73.9 (11.4) 75.0 (12.2) <0.0001
Renal dysfunction (%) 20.4 15.5 15.7 12.7 10.8 13.1 0.0004
NT-proBNP (pg/mL)* 105.6 (45–207) 88.2 (41–183) 85.6 (41–165) 87.4 (45–157) 86.5 (42–159) 101.5 (51–198) 0.04
(Age-adjusted) (95.6) (87.4) (85.6) (85.6) (89.1) (111.0) 0.07
Developed CHD (%) 13.1 11.5 9.6 8.0 8.5 8.0 0.08
Mean (SD) unless specified.
Data on alcohol not available in three men.
*Geometric mean and IQR.
BMI, body mass index; BP, blood pressure; CHD, coronary heart disease; eGFR, estimated glomerular filtration rate; FEV1, forced expiratory volume in 1 s; GGT, γ-glutamyl-transpeptidase;
HDL-C, high-density lipoprotein cholesterol; HF, heart failure; LVH, left ventricular hypertrophy; MI, myocardial infarction; NT-proBNP, N-terminal pro-brain natriuretic peptide; SBP, systolic blood
pressure.
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reference group. The number of heavy drinkers (≥35
drinks/week) in the oldest age group (n=39) was too few
to examine separately. In men <70 years (N=2183;86
cases), the relative risk (95% CI) adjusted for factors in
model 2 (table 2) using non-drinkers and <1 drink/week
combined as the reference group were 1.00, 0.89 (0.46 to
1.75), 0.67 (0.30 to 1.53), 2.37 (1.13 to 4.98) and 2.67
(1.15 to 6.19) for none or <1, 1–6, 7–14, 15–34 and ≥35
drinks/week, respectively. No association was seen in the
older age group (N=1347; 112 cases). The relative risks in
those ≥70 years were 1.00, 0.84 (0.51 to 1.37), 0.91 (0.52
to 1.61) and 0.79 (0.42 to 1.48) for none/<1, 1–6, 7–14
and 15–34 drinks/week groups, respectively.
Since NT-proBNP is a marker of cardiac damage, we
further examined the association between alcohol intake
and HF risk separately in men with and without ECG
evidence of myocardial ischaemia (table 3). To achieve
sufﬁcient numbers, the non-drinkers and those reporting
<1 drink/week were combined, and the 7–14 and 14–34
drinks/week groups were combined, creating four
Figure 1 Kaplan-Meier curve of
cumulative heart failure (HF)
incidence by alcohol intake in
men with no diagnosed
myocardial infarction (MI). Log
rank test p=0.14. Drinks/week
1=none; 2=<1; 3=1–6; 4=7–14;
5=15–34; 6=≥35 (heavy).
Table 2 Heart failure rates/1000 person-years and adjusted HR for heart failure according to alcohol consumption in men
with no pre-existing diagnosed myocardial infarction (MI) or heart failure
Alcohol intake (drinks/week)
Non-drinker
(N=344)
<1
(N=338)
1–6
(N=1259)
7–14
(N=712)
15–34
(N=740)
≥35
(N=137)
Rates/1000
person-years
(n)
6.9 (21) 7.9 (25) 5.2 (64) 5.0 (34) 5.9 (42) 9.4 (12)
Age-adjusted 1.19 (0.71 to 1.92) 1.54 (0.96 to 2.48) 1.00 0.98 (0.65 to 1.49) 1.17 (0.80 to 1.73) 2.04 (1.10 to 3.77)
Model 1 0.98 (0.59 to 1.63) 1.43 (0.89 to 2.32) 1.00 0.94 (0.62 to 1.43) 1.15 (0.78 to 1.70) 1.90 (1.02 to 3.54)
Model 2 1.01 (0.61 to 1.61) 1.49 (0.92 to 2.32) 1.00 0.95 (0.63 to 1.45) 1.19 (0.81 to 1.76) 1.89 (1.01 to 3.52)
Model 3 0.97 (0.59 to 1.63) 1.39 (0.86 to 2.25) 1.00 0.94 (0.64 to 1.43) 1.16 (0.78 to 1.71) 1.91 (1.02 to 3.56)
Model 4 0.94 (0.57 to 1.58) 1.44 (0.86 to 2.29) 1.00 0.93 (0.58 to 1.36) 1.14 (0.76 to 1.67) 1.80 (0.96 to 3.36)
Model 5 0.92 (0.55 to 1.56) 1.28 (0.75 to 2.10) 1.00 0.93 (0.61 to 1.43) 1.14 (0.76 to 1.69) 1.43 (0.76 to 1.69)
Model 6 0.93 (0.55 to 1.57) 1.38 (0.84 to 2.29) 1.00 1.02 (0.66 to 1.56) 1.22 (0.82 to 2.82) 1.56 (0.81 to 3.00)
Model 2 and
exclusion of
past heavy
drinkers (>6
drinks/day)
0.95 (0.57 to 1.58) 1.38 (0.85 to 2.24) 1.00 0.99 (0.65 to 1.51) 1.15 (0.76 to 1.74) 1.83 (0.98 to 3.40)
Model 1: adjusted for age, smoking, body mass index, social class, prevalent stroke, diabetes and angina.
Model 2: Model 1+left ventricular hypertrophy, antihypertensive drugs and systolic blood pressure.
Model 3: Model 2+atrial fibrillation and renal dysfunction.
Model 4: Model 3+forced expiratory volume in 1 s.
Model 5: Model 4+N-terminal pro-brain natriuretic peptide (NT-proBNP).
Model 6: Model 5+incident MI.
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alcohol groups overall. Evidence of myocardial ischaemia
was present in about 22% of the men with no diagnosed
MI. Heavy drinking was associated with increased risk of
HF only in those with ECG evidence of myocardial
ischaemia and this remained even after adjustment for
NT-proBNP and exclusion of men with silent MI
(n=102). No association was seen at all between alcohol
intake and HF risk in those with no evidence of myocar-
dial ischaemia. Exclusion of heavy drinkers made little
difference to the ﬁndings in men with no myocardial
ischaemia. In those with ischaemia, those drinking <1
drink/week showed higher risk compared with those
drinking 1–6 drinks/week, but the difference was not sig-
niﬁcant. We carried out a sensitivity analysis restricting
the analyses to the 160 validated cases. This did not
materially change the results. The adjusted relative risks
(model 1) for the four alcohol groups in those with no
ischaemia were 1.02 (0.59 to 1.78), 1.00, 1.14 (0.72 to
1.78) and 1.22 (0.43 to 3.48) respectively, and 1.61 (0.80
to 3.23), 1.00, 1.19 (0.63 to 2.24) and 3.54 (1.36 to 9.23)
in those with ischaemia, respectively.
DISCUSSION
In this study of older British men, there was no evidence
that light-to-moderate drinking (up to 4 drinks/day) was
associated with a beneﬁcial effect on HF risk overall;
non-drinkers showed similar risk to light/moderate drin-
kers (up to 34 drinks/week). Heavy drinking (≥35
drinks/week or ≥5 drinks/day), however, was associated
with a signiﬁcantly increased risk of HF compared with
those drinking 1–6 drinks/week, which was largely seen
in those with ECG evidence of myocardial ischaemia.
Our ﬁndings extends those of previous studies by
examining the effects of both light-to-moderate drinking
as well as heavy drinking on risk of HF and the role of
NT-proBNP, a marker of cardiac damage, and under-
lying myocardial ischaemia.
Light-to-moderate drinking and HF
Previous studies mainly from the USA have suggested
that light-to-moderate drinking is associated with a bene-
ﬁcial effect on HF.5–12 However, recent ﬁndings from a
large Finnish cohort showed no beneﬁcial effect of light
drinking on HF similar to the current ﬁndings.13 Most
of these previous studies were conducted in middle-aged
populations. In one study it was suggested that the
beneﬁt of light-to-moderate drinking is due to its effect
on reducing CHD, which in turn is associated with
reduced rates of HF rather than a direct beneﬁcial
effect of alcohol on HF risk.11 In the US Kaiser
Permanente study, light-to-moderate drinking was asso-
ciated with reduced risk of HF associated with coronary
artery disease (CAD), but no beneﬁt was seen for
light-to-moderate drinking and the risk of non-CAD-
related HF, and heavy drinking >3 drinks/day increased
risk of non-CAD-related HF.7 Older patients with HF
differ from younger patients in that a higher proportion
of older patients with HF have HF with preserved ejec-
tion fraction.15 These patients are less likely to have
CHD and more likely to have hypertension and atrial
ﬁbrillation.16 A high proportion of men without a
history of a doctor diagnosis of an MI in this study who
developed HF did not develop an MI before developing
HF (85%), which would explain the difference in ﬁnd-
ings between this and the younger US cohorts. In con-
trast, CHD is the predominant risk factor for HF with
reduced ejection fraction, which is more common in
Table 3 Age-adjusted mean NT-proBNP and adjusted HR for heart failure according to alcohol consumption in men with
and without ECG evidence of ischaemia
Alcohol intake
<1-week 1–6/week 7–34/week ≥35/week
Men without ECG evidence of myocardial ischaemia
N (cases) 519 (25) 983 (43) 1142 (48) 102 (4)
Age-adjusted mean NT-proBNP 78.3 73.7 75.2 88.2
Model 1 0.94 (0.56 to 1.57) 1.00 1.01 (0.67 to 1.53) 0.99 (0.55 to 2.79)
Model 2 0.84 (0.49 to 1.43) 1.00 1.02 (0.67 to 1.54) 0.83 (0.29 to 2.36)
Model 2 (exclude past heavy drinkers) 0.92 (0.52 to 1.64) 1.00 0.97 (0.63 to 1.51) 0.78 (0.27 to 2.21)
Men with ECG evidence of myocardial ischaemia
N (cases) 163 (21) 276 (21) 310 (28) 35 (8)
Age-adjusted mean NT-proBNP 148.4 145.4 148.0 219.2
Model 1 1.60 (0.85 to 3.02) 1.00 1.11 (0.62 to 2.00) 3.53 (1.52 to 8.24)
Model 2 1.62 (0.84 to 3.11) 1.00 1.13 (0.62 to 2.03) 3.11 (1.27 to 7.57)
Model 2 (excluding silent MI) 1.43 (0.69 to 2.95) 1.00 1.02 (0.54 to 1.90) 3.01 (1.15 to 7.87)
Model 2 (exclude past heavy drinkers) 1.85 (0.88 to 3.88) 1.00 1.32 (0.68 to 2.54) 3.40 (1.36 to 8.50)
Model 1: adjusted for age, smoking, BMI, social class, prevalent stroke, diabetes, angina, LVH, antihypertensive drugs, systolic blood
pressure, atrial fibrillation, renal dysfunction and FEV1.
Model 2: Model 1+NT-proBNP.
Past heavy drinkers=those ever reporting drinking ≥6 drinks/day.
BMI, body mass index; FEV1, forced expiratory volume in 1 s; LVH, left ventricular hypertrophy; MI, myocardial infarction; NT-proBNP,
N-terminal pro-brain natriuretic peptide.
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younger adults.16 This may explain the overall lower risk
of HF associated with light-to-moderate drinking seen in
many of the previous studies which have been con-
ducted in younger populations. The association between
alcohol and HF in older adults has been less well
studied. In the Cardiovascular Health Study of men
aged >65 years, a weak but non-signiﬁcant inverse associ-
ation was seen between light-to-moderate alcohol intake
and HF in those without CVD.8
The magnitude of the health effects of alcohol is
dependent on the base group used; non-drinkers and
infrequent drinkers are usually not an appropriate group
to estimate the effects of alcohol.29 For comparison pur-
poses with other studies, when non-drinkers and infre-
quent drinkers were used as the comparison group, we
showed a weak and non-signiﬁcant protective effect of
light-to-moderate drinking on HF risk in this older popu-
lation. Our ﬁndings are not dissimilar to that seen in the
Cardiovascular Health Study. However, the inconsistent
ﬁndings that non-drinkers and the infrequent drinkers
had different risk patterns for HF does not provide con-
vincing evidence for a protective effect of alcohol on HF
in older men. This is in contrast to CHD events where
there was a clear inverse relation between alcohol drink-
ing and the percentage of men who developed an MI in
this study, as expected. Moreover, there was no associ-
ation at all between alcohol intake and HF in the large
group of men with no evidence of myocardial ischaemia.
While we cannot exclude the possibility that light-to-
moderate drinking may have some protective effect in
men with ischaemia, we cannot conﬁrm this in our study.
Heavy drinking, NT-proBNP and HF risk
It is well established that excessive alcohol intake, usually
deﬁned as >90 g/day (more than 9 standard UK drinks),
can lead to cardiomyopathy,3 which in turn leads to left
ventricular dysfunction and HF.2 Most studies on heavy
drinking and cardiomyopathy have been conducted in
alcoholic patients, in whom detectable changes in
cardiac structure are seen in those who report drinking
>90 g/day.3 However, few studies have been able to
examine the impact of heavier drinking below this
threshold on HF risk in the general population because
of the low prevalence of heavy drinkers in these study
populations. Most population studies in the US which
have investigated the association between alcohol and
incident HF have focused on the beneﬁts of light drink-
ing and no increased risk is seen with heavier drinking,
usually deﬁned as just >2 drinks/day. However, in the
US Kaiser Permanente study, heavy drinking deﬁned as
>3 drinks/day was shown to be associated with
non-CAD-related HF.7 In a Swedish population study,
men who reported history of alcohol abuse showed
increased risk of HF.30 We have shown that risk of HF is
increased in men consuming 5 or more drinks/day, the
majority of whom reported drinking <8 drinks/day.
These ﬁndings are in keeping with those from the
Copenhagen Study which showed that risk of incident
atrial ﬁbrillation, a major risk factor for HF, is only
increased at levels of 5 drinks or more.17 We observed
no association between alcohol intake and prevalent atrial
ﬁbrillation. However, this may be due to the fact that
many men with atrial ﬁbrillation are likely to develop
stroke or CVD, and have reduced their intake as a result
of developing CVD.
NT-proBNP, a peptide released from myocardium in
response to ventricular wall stress and dysfunction, is a
marker of myocardial damage and subclinical cardiac
function, and is strongly related to incident atrial ﬁbrilla-
tion and HF.23 31 A recent report has shown NT-proBNP
to be increased in heavy drinkers in a population-based
study32 which is consistent with our ﬁndings. We have
shown that the effect of heavy drinking on incident HF
risk was to a large extent associated with NT-proBNP.
This may reﬂect a direct toxic effect of alcohol on the
myocardium with consequent effects on cardiac function
and ventricular wall stress, as has been suggested.32
Further subsidiary analysis showed that heavy drinking
(≥5 drinks/day) increased risk only in those with ECG
evidence of myocardial ischaemia and this was only
partly due to raised NT-proBNP. Thus, regular heavy
drinking appears to have adverse effects on HF risk, par-
ticularly in the presence of myocardial ischaemia where
it may aggravate the myocardial damage or dysfunction
leading to HF.
Limitations
There are several limitations in this study. The current
ﬁndings are based on doctor-diagnosed HF, which is
likely to underestimate the true incidence of HF in this
study population; however, these diagnoses are usually
supported by evidence from hospital admissions and hos-
pital attendances investigation. These men who were sur-
vivors of an ongoing cohort study and attended the
re-examination may have been healthier than the
general older population which might have also affected
the absolute incident rates of HF. However, this should
not have affected the associations between alcohol and
HF risk; our previous reports on HF predictors, such as
obesity and NT-proBNP, in this cohort have generally
accorded with prior data and therefore, suggest external
validity for our ﬁndings.22 23 Echocardiographic mea-
surements were not carried out in the present study and
we were not able to differentiate HF with reduced ejec-
tion fraction and HF with preserved ejection fraction. We
did not have information on incident atrial ﬁbrillation to
assess the possible mediating role of atrial ﬁbrillation.
Although we did not see a signiﬁcant effect for
light-to-moderate drinkers, the number of men drinking
<1 week in this study was small and the CIs do not
exclude such an effect completely because of the size
and power of the study. Although we excluded past heavy
drinkers, higher levels of alcohol consumption may have
been under-reported, leading to a misclassiﬁcation of
heavier drinkers into lower consumption categories.
Such a misclassiﬁcation may have attenuated any
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protective effects present among true light-to-moderate
drinkers. Finally, it was based on an older, predominantly
white, male population of European origin, so that the
results cannot be generalised directly to women, or to
younger populations or other ethnic groups.
CONCLUSION
In this study of older British men, there is no evidence
that light-to-moderate drinking is beneﬁcial for the pre-
vention of HF in men without MI; heavier drinking ≥5
drinks/day is associated with increased risk of HF, par-
ticularly in men with underlying myocardial ischaemia.
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